General MedicationsINJECTIONStandard
CYRAMZA
RAMUCIRUMAB
Standard Dose
500MG/50ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CYRAMZA is listed in Drugs@FDA under application 125477 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RAMUCIRUMAB Form and strength INJECTABLE;INJECTION - 500MG/50ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2025-08-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYRAMZA is listed in Drugs@FDA under application 125477 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient RAMUCIRUMAB Form and strength INJECTABLE;INJECTION - 500MG/50ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2025-08-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.